Business
ImpediMed Appoints Medical Technology Commercialization Expert Erik Anderson to Board of Directors
ImpediMed, a leader in the development and commercialization of medical technologies to clinically monitor and manage fluid and body composition, today announced the appointment of Erik Anderson to its Board of Directors.
About this update from Impedimed Limited
[{"type":"text","content":"Former Hologic executive brings nearly two decades of success in hospital sales and commercialization expertise to medical technology leader's board","length":152,"tagName":"p","attribs":{}},{"type":"text","content":"CARLSBAD, Calif., Feb. 25, 2026 /PRNewswire/ -- ImpediMed, a leader in the development and commercialization of medical technologies to clinically monitor and manage fluid and body composition, today announced the appointment of Erik Anderson to its Board of Directors.","length":274,"tagName":"p"},{"type":"image","alt":"ImpediMed is a medical technology company that non-invasively measures, monitors, and manages fluid status and tissue composition using bioimpedance spectroscopy (BIS). ImpediMed produces a family of FDA cleared and CE Marked medical devices, including the SOZO® Digital Health Platform that is used to assess secondary lymphedema with a focus on breast cancer-related lymphedema. (PRNewsfoto/ImpediMed)","displaySize":"","headline":null,"caption":"ImpediMed is a medical technology company that non-invasively measures, monitors, and manages fluid status and tissue composition using bioimpedance spectroscopy (BIS). ImpediMed produces a family of FDA cleared and CE Marked medical devices, including the SOZO® Digital Health Platform that is used to assess secondary lymphedema with a focus on breast cancer-related lymphedema. (PRNewsfoto/ImpediMed)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":71,"url":"https://media.zenfs.com/en/prnewswire.com/0bef8cb79073ab18bb4446bf5d41f35d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/4PPKr8JeaQ84yKuBY1.dLw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEyNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/0bef8cb79073ab18bb4446bf5d41f35d","width":400,"height":71}},"href":"https://mma.prnewswire.com/media/2340889/IPD_Blue_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Mr. Anderson brings to ImpediMed more than 16 years of experience in US hospital sales, health system account management, and the commercialization of innovative clinical technologies. His experience spans breast health, body composition and medical aesthetics, bringing direct commercial relevance across Impedimed's breast cancer related lymphedema (BCRL), body composition, and heart health growth priorities.","length":416,...